# | Title | Journal | Year | Citations |
---|
1 | Diagnostic criteria for Sweet's syndrome | Cutis | 1986 | 284 |
2 | Skin metastases in cancer patients | Cutis | 1987 | 189 |
3 | The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea | Cutis | 2002 | 142 |
4 | Alpha hydroxy acids: procedures for use in clinical practice | Cutis | 1989 | 139 |
5 | Common dermatologic disorders in skin of color: a comparative practice survey | Cutis | 2007 | 114 |
6 | Efficacy and safety of a new triple-combination agent for the treatment of facial melasma | Cutis | 2003 | 107 |
7 | Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications | Cutis | 2011 | 86 |
8 | Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study | Cutis | 2001 | 83 |
9 | Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance | Cutis | 2007 | 82 |
10 | UV radiation-induced immunosuppression and skin cancer | Cutis | 2004 | 80 |
11 | Silicone gel sheeting in scar therapy | Cutis | 1995 | 78 |
12 | Response to cosmetic disfigurement: patients with vitiligo | Cutis | 1987 | 75 |
13 | Epidemiology and prevention of skin and soft tissue infections | Cutis | 2004 | 75 |
14 | The pathophysiology of photoaging of the skin | Cutis | 2005 | 75 |
15 | Acne vulgaris in the United States: a descriptive epidemiology | Cutis | 2010 | 75 |
16 | Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment | Cutis | 2004 | 74 |
17 | Brittle nails: response to daily biotin supplementation | Cutis | 1993 | 73 |
18 | Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders | Cutis | 1998 | 73 |
19 | Sweet's syndrome: clinical spectrum and associated conditions | Cutis | 1989 | 72 |
20 | Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference | Cutis | 2002 | 71 |
21 | Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review | Cutis | 2006 | 71 |
22 | Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study | Cutis | 2006 | 70 |
23 | Tattoo removal with the Q-switched ruby laser and the Q-switched Nd:YAGlaser: a comparative study | Cutis | 1995 | 69 |
24 | Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria | Cutis | 1994 | 69 |
25 | Temporary hair removal in patients with hirsutism: a clinical study | Cutis | 1990 | 67 |
26 | Laser abrasion for cosmetic and medical treatment of facial actinic damage | Cutis | 1989 | 67 |
27 | Hair and scalp disorders in blacks | Cutis | 1983 | 67 |
28 | Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks | Cutis | 2002 | 66 |
29 | Alternative therapies commonly used within a population of patients with psoriasis | Cutis | 1996 | 65 |
30 | Pyogenic granuloma | Cutis | 2004 | 65 |
31 | Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis | Cutis | 2004 | 64 |
32 | Report of an association between discoid lupus erythematosus and smoking | Cutis | 1999 | 63 |
33 | Efficacy and safety of treatment modalities for psoriasis | Cutis | 1998 | 62 |
34 | Skin manifestations of leukemias and lymphomas | Cutis | 1978 | 61 |
35 | Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports | Cutis | 1996 | 61 |
36 | Topical niacinamide and barrier enhancement | Cutis | 2002 | 61 |
37 | Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea | Cutis | 2005 | 61 |
38 | Nail psoriasis | Cutis | 1992 | 60 |
39 | Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study | Cutis | 1999 | 60 |
40 | Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne | Cutis | 1995 | 59 |
41 | Cutaneous dental sinus tract, a common misdiagnosis: a case report and review of the literature | Cutis | 2002 | 58 |
42 | Treatment of pyoderma gangrenosum with methotrexate | Cutis | 1996 | 57 |
43 | Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma | Cutis | 2005 | 57 |
44 | Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial | Cutis | 2010 | 57 |
45 | Safety and efficacy of a new extended-release formulation of minocycline | Cutis | 2006 | 56 |
46 | Minocycline hyperpigmentation: skin, tooth, nail, and bone involvement | Cutis | 1984 | 55 |
47 | The interaction between acne vulgaris and the psyche | Cutis | 2002 | 55 |
48 | The pathophysiology of acne | Cutis | 2005 | 55 |
49 | Dermatologic changes after systemic cancer therapy | Cutis | 1981 | 54 |
50 | Reactive perforating collagenosis of diabetes mellitus and renal failure | Cutis | 1983 | 54 |